Autres langues Cellectis S.A.

Actions

ALCLS

FR0010425595

Marché Fermé - Euronext Paris Autres places de cotation 17:35:24 30/04/2024			Après clotûre 21:59:42
2,435 ^EUR	-0,61 %		2,43	-0,21 %

09:02	Après Microsoft, Alphabet, Tesla et Apple, Amazon doit faire le job
08:42	En Direct des Marchés : Thales, Stellantis, Capgemini, Atos, VusionGroup, Orpea, Adidas, HSBC...

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cellectis S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023	29/04
Cellectis S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	26/04
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	25/04
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	24/04
Cellectis Presents Novel TALEN Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs	23/04
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs	22/04
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs	22/04
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	22/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	19/04
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	16/04
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	15/04
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	11/04
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs	10/04
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	09/04
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting	08/04
Cellectis S A : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social	05/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading	03/04
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading	02/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Le gros coup de Cellectis

Le 01 novembre 2023 à 09:17